InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Invus US Partners LLC. Officer active across 1 company, notably Lexicon Pharmaceuticals, INC.. Aggregated, 2 disclosures have been logged. Split: 2 buys · 0 sell. Total volume traded: €2.8m. History available since 1 August 2022. The latest transaction was filed on 5 August 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations